002206_0630_havrilesky011

First Page		Document Content
Date: 2014-06-26 09:17:42 Ovarian cancer Ovarian Cancer National Alliance University of Texas MD Anderson Cancer Center Endometrial cancer Cancer research Dana–Farber Cancer Institute Galena Biopharma Medicine Gynaecological cancer Cancer organizations		002206_0630_havrilesky011 Add to Reading List Source URL: www.foundationforwomenscancer.org Download Document from Source Website File Size: 742,03 KB Share Document on Facebook

	Research A population-based analysis of patients with early-stage HER2-positive breast cancer DocID: 1aqN0 - View Document
	(Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc. DocID: Zi3X - View Document
	Microsoft Word - FSI Press Release_Final-19Jan15 DocID: Z8U2 - View Document
	Early breast cancer Initial PBS authority application and supporting information Purpose of this form DocID: VzNP - View Document
	Draft protocol to guide the assessment of HER2 testing in advanced gastric cancer DocID: SVaO - View Document